Financings in Brief: PolyMedica
This article was originally published in The Gray Sheet
Executive SummaryPolyMedica: Wound dressing, catheter kit, and polyurethane materials firm announces a public offering of 700,000 shares, to be sold through Jefferies & Company and Rodman & Renshaw for $6.50 each. Proceeds will fund "research and development, the promotion of new products, the acquisition of related or complementary businesses or products and other general corporate purposes," the Woburn, Massachusetts-based firm says...
You may also be interested in...ï»¿
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.